搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pyrococcus abyssi Putative translation initiation factor eIF-2B subunit 2 (aIF-2BII) CSB-YP895550FHV
CSB-EP895550FHV
CSB-BP895550FHV
CSB-MP895550FHV
CSB-EP895550FHV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus abyssi Molybdopterin synthase catalytic subunit (moaE) CSB-YP895551FHV
CSB-EP895551FHV
CSB-BP895551FHV
CSB-MP895551FHV
CSB-EP895551FHV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus abyssi 2-phosphoglycerate kinase (pgk2) CSB-YP895552FHV
CSB-EP895552FHV
CSB-BP895552FHV
CSB-MP895552FHV
CSB-EP895552FHV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus abyssi Replication factor C large subunit (rfcL) CSB-YP895553FHV
CSB-EP895553FHV
CSB-BP895553FHV
CSB-MP895553FHV
CSB-EP895553FHV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus abyssi 7-cyano-7-deazaguanine synthase (queC) CSB-YP895554FHV
CSB-EP895554FHV
CSB-BP895554FHV
CSB-MP895554FHV
CSB-EP895554FHV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus abyssi Cobalamin synthase (cobS), partial CSB-YP895555FHV1
CSB-EP895555FHV1
CSB-BP895555FHV1
CSB-MP895555FHV1
CSB-EP895555FHV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus abyssi Cell division protein FtsZ 1 (ftsZ1) CSB-YP895556FHV
CSB-EP895556FHV
CSB-BP895556FHV
CSB-MP895556FHV
CSB-EP895556FHV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum 50S ribosomal protein L18e (rpl18e) CSB-YP895557HTM
CSB-EP895557HTM
CSB-BP895557HTM
CSB-MP895557HTM
CSB-EP895557HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable cytochrome P450 303a1 (Cyp303a1), partial CSB-YP895558DLU
CSB-EP895558DLU
CSB-BP895558DLU
CSB-MP895558DLU
CSB-EP895558DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Coproporphyrinogen-III oxidase (Coprox) CSB-YP895559DLU
CSB-EP895559DLU
CSB-BP895559DLU
CSB-MP895559DLU
CSB-EP895559DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster V-type proton ATPase subunit H (VhaSFD) CSB-YP895560DLU
CSB-EP895560DLU
CSB-BP895560DLU
CSB-MP895560DLU
CSB-EP895560DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Nuclear cap-binding protein subunit 2 (Cbp20) CSB-YP895561DLU
CSB-EP895561DLU
CSB-BP895561DLU
CSB-MP895561DLU
CSB-EP895561DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Very long-chain-fatty-acid--CoA ligase bubblegum (bgm), partial CSB-YP895562DLU
CSB-EP895562DLU
CSB-BP895562DLU
CSB-MP895562DLU
CSB-EP895562DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Anamorsin homolog (l (2)35Bg) CSB-YP895563DLU
CSB-EP895563DLU
CSB-BP895563DLU
CSB-MP895563DLU
CSB-EP895563DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster UPF0428 protein CG16865 (CG16865) CSB-YP895564DLU
CSB-EP895564DLU
CSB-BP895564DLU
CSB-MP895564DLU
CSB-EP895564DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Transcription elongation factor SPT5 (Spt5), partial CSB-YP895565DLU
CSB-EP895565DLU
CSB-BP895565DLU
CSB-MP895565DLU
CSB-EP895565DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Calsyntenin-1 (cals), partial CSB-YP895566DLU
CSB-EP895566DLU
CSB-BP895566DLU
CSB-MP895566DLU
CSB-EP895566DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative gustatory receptor 43a (Gr43a), partial CSB-YP895567DLU1
CSB-EP895567DLU1
CSB-BP895567DLU1
CSB-MP895567DLU1
CSB-EP895567DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable cytochrome P450 6a13 (Cyp6a13) CSB-YP895568DLU
CSB-EP895568DLU
CSB-BP895568DLU
CSB-MP895568DLU
CSB-EP895568DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable cytochrome P450 4p3 (Cyp4p3), partial CSB-YP895569DLU
CSB-EP895569DLU
CSB-BP895569DLU
CSB-MP895569DLU
CSB-EP895569DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>